| 52.90 BATS BZX Real-Time Price As of 11:46am ET |  +1.63 / +3.18%Today’s Change | 20.10 Today|||52-Week Range 300.00 | -25.01% Year-to-Date |
| Previous close | 51.27 |
| Today’s open | 51.47 |
| Day’s range | 51.44 - 53.63 |
| Volume | 921,434 |
| Average volume (3 months) | 2,432,512 |
| Market cap | $4.7B |
| Earnings growth (last year) | -873.51% |
| Earnings growth (this year) | -40.70% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +110.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 23.10 |
| Today’s change | Today’s % change | |
|---|---|---|
| NKTRNektar Therapeutics | +0.23 | +0.72% |
| ONCESpark Therapeutics I... | -2.91 | -2.61% |
| BPMCBlueprint Medicines ... | -0.15 | -0.20% |
| ALLOAllogene Therapeutic... | +1.11 | +3.97% |
| Next reporting date | May 15, 2019 |
| EPS forecast (this quarter) | -$0.29 |
| Annual revenue (last year) | $43.1M |
| Annual profit (last year) | -$67.7M |
| Net profit margin | -157.02% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Brendan Kennedy |
Executive Vice President- Operations Greg Christopher |
Corporate headquarters Nanaimo, British Columbia |
